What insurance policy changes affect code G81.00?

There are 4 tracked policy changes affecting code G81.00, including updates from Aetna. Each change may modify coverage criteria, reimbursement rates, or prior-authorization requirements.

Which payers have updated policy for code G81.00?

Payers that have issued tracked updates for code G81.00 include: Aetna.

How do I get notified when code G81.00 policy changes?

Create a free account at PolicyChanges.app and save a search filtered to code G81.00. You will get an email when new policy changes reference this code: daily or weekly, your choice, on every plan.

Why do payers change policies for code G81.00?

Payers revise policies for individual billing codes to align with updated clinical guidelines, CMS rule changes, fraud and abuse prevention measures, or network cost-management goals. Changes can affect medical necessity criteria, place-of-service restrictions, bundling rules, or whether a code requires prior authorization.

PAYER POLICY CHANGES

G81.00 Insurance Policy Changes

ICD-10 G81.00 is officially defined as "Flaccid hemiplegia affecting unspecified side." code G81.00 is referenced in 4 tracked payer policy changes from Aetna. For billers and coders, staying current on payer-specific coverage criteria, reimbursement rules, and prior-authorization requirements for code G81.00 is critical to clean claim submission. Each entry below links to the full policy analysis with effective dates and action steps.

Aetna · Identified Oct 26, 2026Medium impact
Pulsed Radiofrequency (CPB 0735, reviewed 2026-10-21)
Aetna's Clinical Policy Bulletin 0735 considers pulsed radiofrequency experimental, investigational, or unproven for all indications in its list, because its effectiveness has not been established. The list includes indications such as carpal tunnel syndrome, chronic knee pain, low back pain, trigeminal neuralgia, and headache. The policy also considers the Stimpod NMS460 nerve stimulator for post-amputation pain, combined ganglion impar block and pulsed radiofrequency for pudendal neuralgia, and combined platelet-rich plasma to the Gasserian ganglion and pulsed radiofrequency for trigeminal neuralgia experimental, investigational, or unproven.
Aetna · Identified Oct 4, 2026Medium impact
Suit Therapy (CPB 0696, reviewed 2026-09-18)
Suit therapy, including the Adeli Suit, TheraTogs and other suit therapy devices, is considered experimental, investigational or unproven for cerebral palsy and other conditions, including gait rehabilitation following stroke. Dynamic movement orthoses are considered experimental, investigational or unproven for cerebral palsy, hemiparesis or hemiplegia, scoliosis and all other indications. The Dynamic Lycra Suit TLSO brace is considered experimental for cerebral palsy or scoliosis, and a TLSO is considered experimental for autism. The Benik vest or trunk support is considered experimental for individuals with low trunk tone and all other indications.
Aetna · Identified Aug 17, 2026Medium impact
Ambulatory Assist Devices: Canes, Crutches, and Walkers (CPB 0505, reviewed 2026-08-03)
Aetna considers canes, crutches, and walkers medically necessary durable medical equipment when the member has a mobility limitation that significantly impairs participation in one or more mobility-related activities of daily living (MRADL) in the home, the member can safely use the device, and the functional deficit can be sufficiently resolved by the device. Axillary, articulated, spring-assisted crutches, sit-and-stand walking assistant crutches, walkers with enclosed frames, walking belts, and standard strollers are not considered medically necessary, and enhancement accessories such as style, color, seat attachments, tray attachments, baskets, or cup holders are not covered. The AutoAmbulator, battery or electronic powered walkers such as the Sully Walker, the Upsee mobility device, and the wearable freezing of gait detection system are considered experimental, investigational, or unproven.
Aetna · Identified Aug 17, 2026Medium impact
Suit Therapy (CPB 0696, reviewed 2025-11-26)
Aetna considers suit therapy, including home use of suit therapy devices such as the Adeli Suit and TheraTogs, experimental, investigational, or unproven for members with cerebral palsy or other conditions, such as gait rehabilitation following stroke. Aetna also considers dynamic movement TLSO braces (Dynamic Lycra Suits) for cerebral palsy or scoliosis, Dynamic Movement Orthoses for cerebral palsy, hemiparesis or hemiplegia, scoliosis and all other indications, TLSO braces for autism, and the Benik vest for low trunk tone and all other indications experimental, investigational, or unproven.

Watch G81.00

Get one email when a payer policy names G81.00, a payer adds or drops it from a prior auth list, or Medicare changes its NCCI pairs, unit limit, payment or coverage articles.

Get alerts for changes like this

Save a search and get email alerts when a new policy change matches your filters: daily or weekly, your choice, on every plan.

Create a free alert How Policy Monitoring works

Pulsed Radiofrequency (CPB 0735, reviewed 2026-10-21)

Suit Therapy (CPB 0696, reviewed 2026-09-18)

Ambulatory Assist Devices: Canes, Crutches, and Walkers (CPB 0505, reviewed 2026-08-03)

Suit Therapy (CPB 0696, reviewed 2025-11-26)

What insurance policy changes affect code G81.00?

Which payers have updated policy for code G81.00?

How do I get notified when code G81.00 policy changes?

Why do payers change policies for code G81.00?